<i>In-Vitro</i> Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan
Author | Yue Cao | en |
Author | Li-Li Shi | en |
Author | Qing-Ri Cao | en |
Author | Mingshi Yang | en |
Author | Jing-Hao Cui | en |
Issued Date | 2016-04-30 | en |
Abstract | Poorly water-soluble drugs often suffer from limited or irreproducible clinical response due to their low solubility and dissolution rate. In this study, organic solvent-free solid dispersions (OSF-SDs) containing telmisartan (TEL) were prepared using polyvinylpyrrolidone K30 (PVP K30) and polyethylene glycol 6000 (PEG 6000) as hydrophilic polymers, sodium hydroxide (NaOH) as an alkalizer, and poloxamer 188 as a surfactant by a lyophilization method. In-vitro dissolution rate and physicochemical properties of the OSF-SDs were characterized using the USP I basket method, differential scanning calorimetry (DSC), X-ray diffractometry (XRD) and fourier transform-infrared (FT-IR) spectroscopy. In addition, the oral bioavailability of OSF-SDs in rats was evaluated by using TEL bulk powder as a reference. The dissolution rates of the OSF-SDs were significantly enhanced as compared to TEL bulk powder. The results from DSC, XRD showed that TEL was molecularly dispersed in the OSF-SDs as an amorphous form. The FT-IR results suggested that intermolecular hydrogen bonding had formed between TEL and its carriers. The OSF-SDs exhibited significantly higher AUC0–24 h and Cmax, but similar Tmax as compared to the reference. This study demonstrated that OSF-SDs can be a promising method to enhance the dissolution rate and oral bioavailability of TEL. | en |
DOI | https://doi.org/10.22037/ijpr.2016.1839 | en |
Keyword | Telmisartan | en |
Keyword | Solid dispersions | en |
Keyword | Organic Solvent-free | en |
Keyword | <i>In-vitro </i>characterization | en |
Keyword | Oral bioavailability | en |
Publisher | Brieflands | en |
Title | <i>In-Vitro</i> Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan | en |
Type | Original Article | en |